Is the Rehabilitation Robotic a Safe and Effective Choice for Stroke Patients?

NCT03290833 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2019-09-13

No results posted yet for this study

Summary

The effectiveness of robotic over conventional therapy is arguable and the best therapy strategy is still not clear. Basing on the existing evidence on motor learning and practice-induced neuroplasticity, the investigators plan to use an exoskeleton robotic hand to enhance the rehabilitation volume in the subacute stage of stroke patients. The robotic system allows intensive and customized training of hand and finger movements. The aim of this study is (1) to establish whether robot assisted therapy provides any additional motor recovery for the hand when administered during the subacute stage in a Chinese adult population diagnosed with stroke; (2) to evaluate the feasibility and efficacy of robot-assisted hand rehabilitation in improving arm function abilities in subacute hemiplegic patients.

Conditions

Interventions

DEVICE

Robotic

Participants will be placed in the robot and practice common hand tasks involving single finger range of motion exercise, grasping, and pinching objects.

OTHER

Conventional therapy

An occupational therapist will provide one-on-one individualized programs focused on arm and hand function. Treatment will include function-oriented specific tasks, such as reach, grasp, transport and release of various objects between different targets.

Sponsors & Collaborators

  • Chung Yuan Christian University

    collaborator UNKNOWN
  • Ten-Chen General Hospital

    lead OTHER

Principal Investigators

  • Chia-yu Hsu, MD · Ten-Chan General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-24
Primary Completion
2019-06-09
Completion
2019-06-09

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03290833 on ClinicalTrials.gov